Career Development Program (CDP)

Scholar. These 5-year, $120,000 USD/year awards support emerging leaders in the blood cancer research field. You must be a highly qualified, early/mid-career laboratory-based investigator who has an impactful and innovative research program focused on hematologic malignancies and/or relevant premalignant conditions. You must hold an independent, tenure-track, faculty-level position and should have substantial research support from a national agency.

Scholar in Clinical Research. These 5-year, $125,000 USD/year awards support highly qualified clinical investigators who hold an independent faculty-level appointment and are conducting independent applied research that will advance the prevention, diagnosis, and/or treatment of hematologic malignancies and/or relevant premalignant conditions. The research must involve patients and be related to your overall clinical activities. You must have substantial support for your research from another source.

Special Fellow. These 2 or 3 year, $75,000 USD/year awards support highly qualified, mentored postdoctoral fellows and instructors who have 3-5 years of postdoctoral research training (as of the award start date) and are continuing a research program of direct relevance to hematological malignancies and/or relevant premalignant conditions. In addition, your Sponsor must have the appropriate experience and funding to mentor you as you engage in blood cancer research. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period.

Fellow. These 3-year, $70,000 USD/year awards support top performing, mentored postdoctoral fellows and instructors who are training for a career in hematological malignancy research and/or treatment and who have up to 3 years of postdoctoral research training (as of the award start date). Your Sponsor must have the appropriate experience and funding to mentor you as you engage in blood cancer research.

The application process has three phases. The first phase is submission and consideration of eligibility. All eligible applicants will be invited to proceed to the Letter of Intent and Full Application phases. All submissions must be made through the Blood Cancer United Research Portal.